New Natural Parathiosteroids from Paragorgia sp.
723/790 m. The material was identified by Dr. Pablo Lo´pez from
the University of Sevilla (Spain). A voucher specimen is deposited
at PharmaMar (ORMA 001992). The frozen organism (90 g) was
triturated and then extracted with 2-propanol (3 × 200 mL). The
combined extracts were concentrated to yield a crude of 1.07 g.
This material was subjected to VLC on Lichroprep RP-18 with a
stepped gradient from H2O to MeOH. Compounds 1a (35 mg), 2a
(2.0 mg), and 3a (5.6 mg) were isolated from fractions eluting with
MeOH by semipreparative HPLC (SymmetryPrep C-18, 7.8 mm
× 150 mm, gradient H2O/CH3CN from 50% to 100% CH3CN, UV
detection).
32.8 (t); 27.2 (t); 24.4 (t); 22.8 (t); 18.6 (q); 16.9 (C19, q); 12.2
(C18, q); LREIMS (70 eV, m/z %): 342 (M+, 4); 84 (100); (+)-
LRFABMS m /z (%): 343 ([M + H]+, 15); 137 (100); (+)-
HRESIMS: m/z 343.2283 [M + H]+ (calcd for C22H31O3, 343.2267).
Synthetic Parathiosteroid A (1a). TsCl (36 mg, 0.18 mmol) in
dry CH3CN (3 mL) was added to a solution of (20S)-3-oxopregna-
1,4-diene-20-carboxylic acid (6) (50 mg, 0.15 mmol) and N-
methylimidazole (35 µL, 0.44 mmol) in dry CH3CN (3 mL) under
an argon atmosphere, and the mixture was stirred under reflux (85
°C) for 1 h. N-Acetylcysteamine (16 µL, 0.14 mmol) was added at
85 °C, and the mixture was stirred at the same temperature for
24 h. Water was added, and the resulting mixture was extracted
with EtOAc (2 × 15 mL). The organic phase was washed with
water, brine, dried (MgSO4), and concentrated. The crude obtained
was subjected to column chromatography (silica gel, n-hexanes/
EtOAc 4:1), and the product was purified by HPLC (Sharlau C18,
flow rate 1 mL/min, retention time 34 min, CH3CN/H2O, 7:3) to
give 1a (32 mg, 65%) as a white amorphous solid. [R]25D +6.8 (c
0.2, MeOH); LREIMS (70 eV, m/z %): 443 (M+, 8); 82 (100);
(+)-LRFABMS, m/z (%): 466 ([M + Na]+, 8); 444 ([M + H]+,
38); 121 (100); (+)-HRESIMS: m/z 444.2550 [M + H]+ (calcd
for C26H38NO3S, 444.2567), 466.2373 [M + Na]+ (calcd for
C26H37NO3SNa, 466.2386).
(3ꢀ,5r,20S)-20-Methylpregnane-3,21-diol (7). A three-necked
flask was fitted with a dropping funnel, a coldfinger condenser filled
with liquid N2 and an inlet tube connected to an ammonia source,
with the gas dried using KOH. Argon was swept through the system
for 10 min and then ammonia (40 mL) was trapped in the flask.
Lithium wire (7 equiv) was cut into small pieces and added. After
stirring for 1 h, (20S)-20-hydroxymethylpregna-1,4-dien-3-one (4)
(1 g, 1.5 mmol) in THF (20 mL) was added dropwise, and the
mixture was stirred at -78 °C over 3 h. The cooling bath was
removed, and the mixture was allowed to warm to -40 °C for 20
min. The flask was dipped into a cooling bath and anhydrous NH4Cl
was added during 2 h (note: take care! vigorous reaction). The
mixture turned white and pasty. Most of the ammonia was removed
with a stream of argon. The residue was diluted with ether, washed
with brine and dried. Evaporation left a white solid that was
subjected to column chromatography (silica gel, n-hexanes/EtOAc
4:1) to afford (20S)-20-methylpregnane-3,21-diol (7) (0.99 g, 99%)
as a white amorphous solid. [R]25D +6.6 (c 0.1, CH2Cl2); 1H NMR
(300 MHz, CDCl3) δ (ppm): 3.75-3.33 (H22, H22′, 2H, m); 3.39
- 3.33 (H3R, 1H, m); 1.26 (H19, 3H, s); 1.04 (H21, 3H, d, J )
6.8 Hz); 0.68 (H18, 3H, s); 13C NMR (75 MHz, CDCl3) δ (ppm):
70.9 (C3, d); 67.6 (C22, t); 55.8 (C14, d); 53.9 (C17, d); 52.1 (d);
44.4 (d); 42.2 (s); 39.4 (s); 38.3 (t); 37.7 (d); 36.5 (t); 35.1 (t);
35.0 (d); 31.6 (t); 31.1 (t); 28.2 (t); 27.3 (t); 23.8 (t); 20.8 (C11, t);
16.2 (C21, q); 11.8 (C19, q); 11.7 (C18, q); LREIMS (70 eV, m/z
%): 334 (M+, 78); 84 (100); (-)-HRESIMS: m/z 333.2894 [M -
H]+ (calcd for C22H37O2, 333.2788).
Parathiosteroid A (1a). Amorphous white solid. [R]25 +5.9
D
(c 0.2, MeOH); IR (KBr) νmax 3291, 3080, 2939, 1657, 1621, 1599,
1550, 1438, 1403, 1371, 1291, 1240, 1204, 1009, 964, 930, 886
1
cm-1; H (500 MHz) and 13C NMR (125 MHz) see Table 1; (+)-
FABMS m/z 444 [M + H]+; (+)-HRFABMS m/z 444.2572 [M +
H]+ (calcd for C26H38NO3S, 444.2567).
Parathiosteroid B (2a). Amorphous white solid. [R]25 +66.2
D
(c 0.2, MeOH); IR (KBr) νmax 3301, 3080, 2939, 1684, 1546, 1442,
1373, 1274, 1262, 1237, 1199, 1176, 1161, 1107, 966, 935 cm-1
;
1H (500 MHz) and 13C NMR (125 MHz) see Table 1; (+)-FABMS
m/z 446 [M + H]+; (+)-HRFABMS m/z 446.2710 [M + H]+ (calcd
for C26H40NO3S, 446.2723).
Parathiosteroid C (3). Amorphous white solid. [R]25 +11.2
D
(c 0.2, MeOH); IR (KBr) νmax 3384, 3148, 2947, 2875, 1679, 1646,
1605, 1572, 1532, 1496, 1452, 1428, 1383, 1359, 1293, 1252, 968
1
cm-1; H (500 MHz) and 13C NMR (125 MHz) see Table 1; (+)-
FABMS m/z 430 [M + H]+; (+)-HRFABMS m/z 430.2420 [M +
H]+ (calcd for C25H36NO3S, 430.2410).
(20S)-3-Oxopregna-1,4-diene-20-carboxaldehyde (5). A mix-
ture of (20S)-20-hydroxymethylpregna-1,4-dien-3-one (4) (1.0 g,
3.0 mmol) with PDC (4.0 g, 10.0 mmol) in anhydrous DMF (50
mL) in the presence of activated molecular sieves was stirred at
room temperature for 5 h. Insoluble materials were filtered off
through a Celite pad, and the filtrate was concentrated in vacuo.
The residue was purified by column chromatography (silica gel,
n-hexanes/EtOAc 4:1) affording (20S)-3-oxopregna-1,4-diene-20-
carboxaldehyde (5) (0.99 g, 99%) as a white amorphous solid. [R]25
D
+13.8 (c 1.4, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ (ppm): 9.55
(H22, 1H, d, J ) 3.0 Hz); 7.04 (H1, 1H, d, J ) 10.1 Hz); 6.23
(H2, 1H, dd, J ) 10.1, 1.9 Hz); 6.07 (H4, 1H, d, J ) 1.7 Hz); 1.23
(H19, 3H, s); 1.12 (H21, 3H, d, J ) 6.8 Hz); 0.78 (H18, 3H, s);
13C NMR (75 MHz, CDCl3) δ (ppm): 204.3 (C22, d); 186.0 (C3,
s); 168.7 (C5, s); 155.4 (C1, d); 127.0 (C2, d); 123.4 (C4, d); 54.3
(C14, d); 51.8 (C17, d); 50.4 (d); 48.9 (d); 43.1 (s); 42.8 (s); 38.6
(d); 35.0 (t); 33.1 (t); 32.3 (t); 26.4 (t); 24.2 (t); 22.3 (t); 18.2 (q);
12.9 (C19, q); 12.0 (C18, q); LREIMS (70 eV, m/z %): 326 (M+,
6); 122 (100); (+)-LRFABMS m /z (%): 327 ([M + H]+, 72); 121
(100).
(20S)-3-Oxopregna-1,4-diene-20-carboxylic Acid (6). (20S)-
3-Oxopregna-1,4-diene-20-carboxaldehyde (5) (0.5 g, 1.5 mmol)
was dissolved in a 1.3:1 CH3CN/pH 6.5 buffer solution mixture
(10 mL). TEMPO (0.13 g, 0.7 mmol), NaClO2 (0.3 g, 0.12 mmol),
and NaClO (2 mL) were added. The mixture was stirred at room
temperature for 24 h, and after that time an aqueous saturated
Na2SO3 solution (25 mL) was added. The pH was set to 3 by adding
aqueous 2 N HCl solution. The mixture was extracted with EtOAc
(3 × 30 mL) and washed with brine (30 mL). The solvent was
dried over anhydrous sodium sulfate and removed under vacuum.
The crude was purified by column chromatography (silica gel,
n-hexanes/EtOAc 7:3) affording the pure (20S)-3-oxopregna-1,4-
Compound 11a. A cold (0 °C) solution of phenyltrimethylam-
monium perbromide (PTAP) (25 mg, 0.65 mmol) in dry THF (3
mL) was added dropwise to a solution of 10a (30 mg, 0.7 mmol)
in dry THF (4 mL) over a period of 3 h. After a further 45 min,
the reaction was quenched by the addition of a saturated sodium
hydrogen carbonate aqueous solution (10 mL). The aqueous layer
was extracted with EtOAc, and the combined organic layers were
washed with water and dried over MgSO4. The crude product was
subjected to column chromatography (silica gel, n-hexanes/EtOAc
4:1), and the product was purified by HPLC (Sharlau C18, flow
rate 1 mL/min, retention time 74 min, CH3CN/H2O, 7:3) to give
diene-20-carboxylic acid (6) (0.37 g, 75%) as a white amorphous
11a (17 mg, 62%) as a white amorphous solid. [R]25 +190.0 (c
D
1
1
solid. [R]25 -18.8 (c 1, CH2Cl2). H NMR (300 MHz, CDCl3) δ
0.1, CH2Cl2); H NMR (300 MHz, CDCl3) δ (ppm): 5.78 (NH,
D
(ppm): 7.05 (H1, 1H, d, J ) 10.1 Hz); 6.24 (H2, 1H, dd, J ) 10.1,
1.9 Hz); 6.08 (H4, 1H, d, J ) 1.4 Hz); 1.24 (H21, 3H, d, J ) 6.6
Hz); 1.23 (H19, 3H, s); 0.78 (H18, 3H, s); 13C NMR (75 MHz,
CDCl3) δ (ppm): 186.5 (C3, s); 181.7 (C22, s); 169.3 (C5, s); 155.9
(C1, d); 127.5 (C2, d); 123.8 (C4, d); 55.0 (C14, d); 52.3 (C17, d);
52.2 (d); 43.5 (s); 42.7 (s); 42.3 (d); 39.3 (t); 35.5 (d); 33.5 (t);
1H, br s.); 4.73 (H2ꢀ, 1H, dd, J ) 13.1, 6.3 Hz); 3.43 (H25, 2H,
m); 2.99 (H24, 2H, m); 2.65 (H4a, 1H, m); 2.42 (H1a, 1H, m);
1.96 (H28, 3H, s); 1.21 (H21, 3H, d, J ) 6.8 Hz); 1.09 (H19, 3H,
s); 0.71 (H18, 3H, s); 13C NMR (75 MHz, CDCl3) δ (ppm): 204.2
(C22, s); 201.1 (C3, s); 170.2 (C27, s); 55.6 (C14, d); 54.4 (C17,
d); 53.5 (C20, d); 52.6 (C9, d); 51.8 (C2, d); 51.6 (C12, t); 47.4
J. Org. Chem. Vol. 73, No. 20, 2008 7983